Expert Reviews: 5 Ways Trump’s FDA May Skip Drug Trials
Under Trump, the FDA is seeking to abandon traditional expert reviews for new drugs. Find out how this major policy shift could impact public health and safety.
Under Trump, the FDA is seeking to abandon traditional expert reviews for new drugs. Find out how this major policy shift could impact public health and safety.
Under Trump, the FDA seeks to abandon expert reviews of new drugs. Learn how this major policy shift could affect the safety and approval process for all new drugs.